» Articles » PMID: 25001172

Inter-scanner Differences in in Vivo QCT Measurements of the Density and Strength of the Proximal Femur Remain After Correction with Anthropomorphic Standardization Phantoms

Overview
Journal Med Eng Phys
Date 2014 Jul 9
PMID 25001172
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In multicenter studies and longitudinal studies that use two or more different quantitative computed tomography (QCT) imaging systems, anthropomorphic standardization phantoms (ASPs) are used to correct inter-scanner differences and allow pooling of data. In this study, in vivo imaging of 20 women on two imaging systems was used to evaluate inter-scanner differences in hip integral BMD (iBMD), trabecular BMD (tBMD), cortical BMD (cBMD), femoral neck yield moment (My) and yield force (Fy), and finite-element derived strength of the femur under stance (FEstance) and fall (FEfall) loading. Six different ASPs were used to derive inter-scanner correction equations. Significant (p<0.05) inter-scanner differences were detected in all measurements except My and FEfall, and no ASP-based correction was able to reduce inter-scanner variability to corresponding levels of intra-scanner precision. Inter-scanner variability was considerably higher than intra-scanner precision, even in cases where the mean inter-scanner difference was statistically insignificant. A significant (p<0.01) effect of body size on inter-scanner differences in BMD was detected, demonstrating a need to address the effects of body size on QCT measurements. The results of this study show that significant inter-scanner differences in QCT-based measurements of BMD and bone strength can remain even when using an ASP.

Citing Articles

A Patient-Specific Fracture Risk Assessment Tool for Femoral Bone Metastases: Using the Bone Strength (BOS) Score in Clinical Practice.

Eggermont F, van der Linden Y, Verdonschot N, Dierselhuis E, Ligthert S, Bitter T Cancers (Basel). 2022; 14(23).

PMID: 36497388 PMC: 9740241. DOI: 10.3390/cancers14235904.


The effect of variations in CT scan protocol on femoral finite element failure load assessment using phantomless calibration.

Ataei A, Eikhout J, van Leeuwen R, Tanck E, Eggermont F PLoS One. 2022; 17(3):e0265524.

PMID: 35303026 PMC: 8932617. DOI: 10.1371/journal.pone.0265524.


Fracture Risk of Long Bone Metastases: A Review of Current and New Decision-Making Tools for Prophylactic Surgery.

Nguyn M, Carlier C, Nich C, Gouin F, Crenn V Cancers (Basel). 2021; 13(15).

PMID: 34359563 PMC: 8345078. DOI: 10.3390/cancers13153662.


Effect of CT imaging on the accuracy of the finite element modelling in bone.

Benca E, Amini M, Pahr D Eur Radiol Exp. 2020; 4(1):51.

PMID: 32869123 PMC: 7458968. DOI: 10.1186/s41747-020-00180-3.


Fracture risk assessment and clinical decision making for patients with metastatic bone disease.

Damron T, Mann K J Orthop Res. 2020; 38(6):1175-1190.

PMID: 32162711 PMC: 7225068. DOI: 10.1002/jor.24660.


References
1.
Keyak J, Kaneko T, Tehranzadeh J, Skinner H . Predicting proximal femoral strength using structural engineering models. Clin Orthop Relat Res. 2005; (437):219-28. DOI: 10.1097/01.blo.0000164400.37905.22. View

2.
Birnbaum B, Hindman N, Lee J, Babb J . Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology. 2006; 242(1):109-19. DOI: 10.1148/radiol.2421052066. View

3.
Keyak J, Rossi S, Jones K, Les C, Skinner H . Prediction of fracture location in the proximal femur using finite element models. Med Eng Phys. 2002; 23(9):657-64. DOI: 10.1016/s1350-4533(01)00094-7. View

4.
Keaveny T, Hoffmann P, Singh M, Palermo L, Bilezikian J, Greenspan S . Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008; 23(12):1974-82. PMC: 2686921. DOI: 10.1359/jbmr.080805. View

5.
Engelke K, Fuerst T, Dasic G, Davies R, Genant H . Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis. Bone. 2010; 46(6):1626-32. DOI: 10.1016/j.bone.2010.03.003. View